Author:
Attama Anthony A.,Kenechukwu Franklin C.,Onuigbo Ebele B.,Nnamani Petra O.,Obitte Nicholas,Finke Jahn H.,Pretor Sascha,Müller-Goymann Christel C.
Abstract
AbstractArtemisinins, the mainstay in the treatment of malaria today, are used in combination with other antimalarials to forestall resistance, as artemisinin-combination therapies. In line with the World Health Organization’s recommendation in that respect, solid lipid nanoparticles (SLN) were formulated to encapsulate two antimalarial drugs — artemether and lumefantrine. The nanoparticles were evaluated for size and solid state properties. Caco-2 cells were used to investigate the ability of the SLN to deliver its payload at the absorptive interface of the gastrointestinal tract. Mice heart endothelial cells (MHEC) were also used as marker cells to assess cellular uptake of coumarin 6 from the SLN with imaging by confocal laser scanning microscopy (CSLM). In vivo antimalarial activity was done using a standard suppressive protocol. The results of this study revealed different crystal properties for artemether and lumefantrine, which affected their solubility in the lipid matrix and thus, loading in the lipid nanoparticles. The particles of the SLN were within the range of 150 nm–500 nm with varied polydispersity indices. Wide angle X-ray diffraction analysis indicated the presence of particles of solid nature. Cellular uptake studies indicated uptake of coumarin 6 from the coumarin 6-labeled SLN. In vivo antimalarial studies indicated high clearance of parasitemia with minimal effect on hematological parameters tested.
Subject
Physical and Theoretical Chemistry,Biomedical Engineering,Medicine (miscellaneous),Bioengineering
Reference40 articles.
1. The use of solid lipid nanoparticles for sustained drug release;Ther Deliv,2015
2. Formulation, characterization and anti-malarial activity of homolipid-based artemether microparticles;Int J Pharm,2015
3. Investigation of diazepam lipospheres based on witepsol and lecithin for oral or rectal delivery;Acta Polon Pharm,2000
4. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization;Eur J Pharm Biopharm,2007
5. Formulation design, in vitro and anti-malarial investigations of artemether and lumenfantrine-entrapped solid lipid microparticles;Drug Dev Ind Pharm,2016
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献